Trial · NCT00886262
Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
NCT00886262, Not applicable, Completed, Medical University of South Carolina; results first posted 2018-10-17
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant. Trials, record NCT00886262. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00886262
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
- NCT number
- NCT00886262
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 18 participants, actual
- Lead sponsor
- Medical University of South Carolina
- Conditions
- Liver Failure
- Interventions
- Vasopressin, Normal saline placebo
- First posted
- 2009-04-22
- Last updated
- 2018-10-17
- Results first posted
- 2018-10-17
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Creatinine Levels | baseline to 48 hours postop | |
| Primary | Change in Urine Output | 24 hours to 48 hours postop | |
| Secondary | Count of Participants Who Needed Diuretics Postoperatively | 48 hours | |
| Secondary | Count of Patient Who Need Vasopressers in the Perioperative Period | 48 hours |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Creatinine Levels | baseline to 48 hours postop | MG/DL | MEAN | |
| PRIMARY | Change in Urine Output | 24 hours to 48 hours postop | mL | MEAN | |
| SECONDARY | Count of Participants Who Needed Diuretics Postoperatively | 48 hours | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Count of Patient Who Need Vasopressers in the Perioperative Period | 48 hours | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group8
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Creatinine Levels | Vasopressin | 0.5 | Full Range 0.1 to 0.8 | MG/DL | |
| Change in Creatinine Levels | Normal Saline Placebo | 0.55 | Full Range 0.1 to 1.3 | MG/DL | |
| Change in Urine Output | Vasopressin | 1353 | Full Range 160 to 2830 | mL | |
| Change in Urine Output | Normal Saline Placebo | 731 | Full Range 10 to 1550 | mL | |
| Count of Participants Who Needed Diuretics Postoperatively | Vasopressin | 4 | Participants | ||
| Count of Participants Who Needed Diuretics Postoperatively | Normal Saline Placebo | 1 | Participants | ||
| Count of Patient Who Need Vasopressers in the Perioperative Period | Vasopressin | 3 | Participants | ||
| Count of Patient Who Need Vasopressers in the Perioperative Period | Normal Saline Placebo | 4 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Vasopressin | 8 | |
| Overall Study | STARTED | Normal Saline Placebo | 10 | |
| Overall Study | COMPLETED | Vasopressin | 8 | |
| Overall Study | COMPLETED | Normal Saline Placebo | 7 | |
| Overall Study | NOT COMPLETED | Vasopressin | 0 | |
| Overall Study | NOT COMPLETED | Normal Saline Placebo | 3 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Vasopressin | 0 | 8 |
| Total, all-cause mortality | Normal Saline Placebo | 0 | 10 |
| Total, other adverse events | Vasopressin | 0 | 8 |
| Total, other adverse events | Normal Saline Placebo | 0 | 10 |
| Total, serious adverse events | Vasopressin | 0 | 8 |
| Total, serious adverse events | Normal Saline Placebo | 0 | 10 |
Source ClinicalTrials.gov
Papers9
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons4
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Vasopressin vs Normal Saline Placebo: Count of Patient Who Need Vasopressers in the Perioperative Period | Trial comparisons |
| Vasopressin vs Normal Saline Placebo: Count of Participants Who Needed Diuretics Postoperatively | Trial comparisons |
| Vasopressin vs Normal Saline Placebo: deaths from any cause | Trial comparisons |
| Vasopressin vs Normal Saline Placebo: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00886262
GET https://conductscience.org/api/trials/v1/NCT00886262/registered